|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-DEPENDENT PATHWAYS CONTRIBUTE TO PDGF-STIMULATED ERK1/2 ACTIVATION IN VASCULAR SMOOTH MUSCLE
1 Cardiovascular Sciences, Albany Medical College, Albany, NY, USA
* To whom correspondence should be addressed. E-mail: singerh{at}mail.amc.edu.
Platelet derived growth factor (PDGF) is an important regulator of vascular smooth muscle cell growth and migration and has been identified as a key mediator of neointima formation resulting from vascular injury. PDGF exerts its effects, in part, through activation of ERK1/2. Previously, we reported that PKC
, specifically compared to PKC
, mediated phorbol ester- and ATP-dependent activation of ERK1/2 in VSM cells. The purpose of this study was to determine whether PKC
was involved in PDGF-dependent activation of ERK1/2 in VSM cells. Addition of PDGF resulted in the activation, and src family kinase-dependent tyrosine phosphorylation, of PKC
. Treatment with rottlerin (0.1-10 µM), a selective PKC
inhibitor, or adenoviral overexpression of kinase-negative PKC
significantly attenuated PDGF-induced activation of ERK1/2. Effects of the PKC
inhibitors decreased with increasing concentrations of activator PDGF. Interestingly, treatment with Go6976 (0.1-3 µM), a selective inhibitor of cPKCs, or adenoviral overexpression of kinase-negative PKC
also inhibited PDGF-stimulated ERK1/2. Furthermore, inhibition of cPKC activity with Go6976 or overexpression of kinase-negative PKC
attenuated PKC
activation and tyrosine phosphorylation in response to PDGF. These studies indicate involvement of both PKC
and PKC
isozymes in PDGF-stimulated signaling in VSM and suggest an unexpected role for PKC
in the regulation of PKC
activity.
This article has been cited by other articles:
![]() |
I. T. Makagiansar, S. Williams, T. Mustelin, and W. B. Stallcup Differential phosphorylation of NG2 proteoglycan by ERK and PKC{alpha} helps balance cell proliferation and migration J. Cell Biol., October 3, 2007; 178(1): 155 - 165. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Papparella, G. Ceolotto, L. Berto, M. Cavalli, S. Bova, G. Cargnelli, E. Ruga, O. Milanesi, L. Franco, M. Mazzoni, et al. Vitamin C prevents zidovudine-induced NAD(P)H oxidase activation and hypertension in the rat Cardiovasc Res, January 15, 2007; 73(2): 432 - 438. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Kilpatrick, S. Sun, D. Mackie, F. Baik, H. Li, and H. M. Korchak Regulation of TNF mediated antiapoptotic signaling in human neutrophils: role of {delta}-PKC and ERK1/2 J. Leukoc. Biol., December 1, 2006; 80(6): 1512 - 1521. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ginnan, B. J. Guikema, H. A. Singer, and D. Jourd'heuil PKC-{delta} mediates activation of ERK1/2 and induction of iNOS by IL-1beta in vascular smooth muscle cells Am J Physiol Cell Physiol, June 1, 2006; 290(6): C1583 - C1591. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |